MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus
-
Published:2024-04-08
Issue:1
Volume:22
Page:
-
ISSN:1478-811X
-
Container-title:Cell Communication and Signaling
-
language:en
-
Short-container-title:Cell Commun Signal
Author:
Wang Tao,Song Dan,Li Xuejuan,Luo Yu,Yang Dianqiang,Liu Xiaoyan,Kong Xiaodan,Xing Yida,Bi Shulin,Zhang Yan,Hu Tao,Zhang Yunyun,Dai Shuang,Shao Zhiqiang,Chen Dahan,Hou Jinpao,Ballestar Esteban,Cai Jianchun,Zheng Feng,Yang James Y.
Abstract
AbstractEndosomal single-stranded RNA-sensing Toll-like receptor-7/8 (TLR7/8) plays a pivotal role in inflammation and immune responses and autoimmune diseases. However, the mechanisms underlying the initiation of the TLR7/8-mediated autoimmune signaling remain to be fully elucidated. Here, we demonstrate that miR-574-5p is aberrantly upregulated in tissues of lupus prone mice and in the plasma of lupus patients, with its expression levels correlating with the disease activity. miR-574-5p binds to and activates human hTLR8 or its murine ortholog mTlr7 to elicit a series of MyD88-dependent immune and inflammatory responses. These responses include the overproduction of cytokines and interferons, the activation of STAT1 signaling and B lymphocytes, and the production of autoantigens. In a transgenic mouse model, the induction of miR-574-5p overexpression is associated with increased secretion of antinuclear and anti-dsDNA antibodies, increased IgG and C3 deposit in the kidney, elevated expression of inflammatory genes in the spleen. In lupus-prone mice, lentivirus-mediated silencing of miR-574-5p significantly ameliorates major symptoms associated with lupus and lupus nephritis. Collectively, these results suggest that the miR-574-5p-hTLR8/mTlr7 signaling is an important axis of immune and inflammatory responses, contributing significantly to the development of lupus and lupus nephritis.
Funder
Postdoctoral Fellowship National Key R&D Program of China National Natural Science Foundation of China Key research and development grant, the Department of Science and Technology, Liaoning, China Innovative Leading Researcher grant, the Department of Science and Technology, Dalian, China The 973 Program of China
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Hornung V, Barchet W, Schlee M, Hartmann G. (2008) RNA recognition via TLR7 and TLR8. Handb Exp Pharmacol, 71–86. 2. Vlach J, Bender AT, Przetak M, Pereira A, Deshpande A, Johnson TL, Reissig S, Tzvetkov E, Musil D, Morse NT, Haselmayer P, Zimmerli SC, Okitsu SL, Walsky RL, Sherer B. Discovery of M5049: a Novel Selective Toll-Like receptor 7/8 inhibitor for treatment of autoimmunity. J Pharmacol Exp Ther. 2021;376:397–409. 3. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526–9. 4. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA. (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A 101, 5598–5603. 5. Biondo C, Malara A, Costa A, Signorino G, Cardile F, Midiri A, Galbo R, Papasergi S, Domina M, Pugliese M, Teti G, Mancuso G, Beninati C. Recognition of fungal RNA by TLR7 has a nonredundant role in host defense against experimental candidiasis. Eur J Immunol. 2012;42:2632–43.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|